T 2342/22 (Universal CAR-T cells/UNIVERSITY of MARYLAND) of 28.05.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T234222.20240528
- Date of decision
- 28 May 2024
- Case number
- T 2342/22
- Petition for review of
- -
- Application number
- 11849221.4
- IPC class
- A61K 31/4188A61P 35/00A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer
- Applicant name
- University of Maryland, Baltimore
- Opponent name
- AvenCell Europe GmbH
Strawman Limited - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84European Patent Convention Art 87Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Main request and auxiliary requests 2,5,7,9,12,13 - lack of clarity
Priority - only partially valid
Auxiliary requests 1, 3, 4, 6, 8, 10, 11, 14 to 18, 20 to 22 - added matter
Auxiliary request 19 - admission (yes)
Auxiliary request 19 - lack of inventive step
Auxiliary request 23 - admission (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.